Assura’s (AGR) Hold Rating Reaffirmed at Shore Capital

Shore Capital reaffirmed their hold rating on shares of Assura (LON:AGR) in a research note published on Wednesday, Marketbeat Ratings reports.

Separately, Peel Hunt reiterated a “buy” rating and issued a GBX 60 price objective on shares of Assura in a report on Tuesday. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 60.

Assura Stock Up 3.1%

LON AGR opened at GBX 48.72 on Wednesday. The business’s fifty day simple moving average is GBX 48.04 and its 200-day simple moving average is GBX 48.48. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. The firm has a market cap of £1.58 billion, a PE ratio of 919.25, a P/E/G ratio of 3.60 and a beta of 0.37. Assura has a 52 week low of GBX 35.24 and a 52 week high of GBX 50.95.

Assura (LON:AGR) last released its quarterly earnings data on Monday, July 21st. The real estate investment trust reported GBX 3.50 earnings per share (EPS) for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. As a group, equities analysts anticipate that Assura will post 3.5830389 earnings per share for the current year.

Insider Transactions at Assura

In other Assura news, insider Jonathan Murphy sold 1,572,585 shares of Assura stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of GBX 50, for a total value of £786,292.50. Also, insider Sam Barrell sold 34,153 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of GBX 48, for a total transaction of £16,393.44. In the last ninety days, insiders have acquired 2,540 shares of company stock valued at $125,674 and have sold 5,182,149 shares valued at $258,872,495. Company insiders own 0.93% of the company’s stock.

Assura Company Profile

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.